Cargando…

伊布替尼治疗过程中华氏巨球蛋白血症向弥漫大B细胞淋巴瘤克隆同源性转化一例报告并文献复习

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595864/
https://www.ncbi.nlm.nih.gov/pubmed/33113611
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.012
_version_ 1783601975325097984
collection PubMed
description
format Online
Article
Text
id pubmed-7595864
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-75958642020-10-30 伊布替尼治疗过程中华氏巨球蛋白血症向弥漫大B细胞淋巴瘤克隆同源性转化一例报告并文献复习 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2020-09 /pmc/articles/PMC7595864/ /pubmed/33113611 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.012 Text en 2020年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
spellingShingle 短篇论著
伊布替尼治疗过程中华氏巨球蛋白血症向弥漫大B细胞淋巴瘤克隆同源性转化一例报告并文献复习
title 伊布替尼治疗过程中华氏巨球蛋白血症向弥漫大B细胞淋巴瘤克隆同源性转化一例报告并文献复习
title_full 伊布替尼治疗过程中华氏巨球蛋白血症向弥漫大B细胞淋巴瘤克隆同源性转化一例报告并文献复习
title_fullStr 伊布替尼治疗过程中华氏巨球蛋白血症向弥漫大B细胞淋巴瘤克隆同源性转化一例报告并文献复习
title_full_unstemmed 伊布替尼治疗过程中华氏巨球蛋白血症向弥漫大B细胞淋巴瘤克隆同源性转化一例报告并文献复习
title_short 伊布替尼治疗过程中华氏巨球蛋白血症向弥漫大B细胞淋巴瘤克隆同源性转化一例报告并文献复习
title_sort 伊布替尼治疗过程中华氏巨球蛋白血症向弥漫大b细胞淋巴瘤克隆同源性转化一例报告并文献复习
topic 短篇论著
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595864/
https://www.ncbi.nlm.nih.gov/pubmed/33113611
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.012
work_keys_str_mv AT yībùtìnízhìliáoguòchéngzhōnghuáshìjùqiúdànbáixuèzhèngxiàngmímàndàbxìbāolínbāliúkèlóngtóngyuánxìngzhuǎnhuàyīlìbàogàobìngwénxiànfùxí
AT yībùtìnízhìliáoguòchéngzhōnghuáshìjùqiúdànbáixuèzhèngxiàngmímàndàbxìbāolínbāliúkèlóngtóngyuánxìngzhuǎnhuàyīlìbàogàobìngwénxiànfùxí
AT yībùtìnízhìliáoguòchéngzhōnghuáshìjùqiúdànbáixuèzhèngxiàngmímàndàbxìbāolínbāliúkèlóngtóngyuánxìngzhuǎnhuàyīlìbàogàobìngwénxiànfùxí
AT yībùtìnízhìliáoguòchéngzhōnghuáshìjùqiúdànbáixuèzhèngxiàngmímàndàbxìbāolínbāliúkèlóngtóngyuánxìngzhuǎnhuàyīlìbàogàobìngwénxiànfùxí
AT yībùtìnízhìliáoguòchéngzhōnghuáshìjùqiúdànbáixuèzhèngxiàngmímàndàbxìbāolínbāliúkèlóngtóngyuánxìngzhuǎnhuàyīlìbàogàobìngwénxiànfùxí
AT yībùtìnízhìliáoguòchéngzhōnghuáshìjùqiúdànbáixuèzhèngxiàngmímàndàbxìbāolínbāliúkèlóngtóngyuánxìngzhuǎnhuàyīlìbàogàobìngwénxiànfùxí
AT yībùtìnízhìliáoguòchéngzhōnghuáshìjùqiúdànbáixuèzhèngxiàngmímàndàbxìbāolínbāliúkèlóngtóngyuánxìngzhuǎnhuàyīlìbàogàobìngwénxiànfùxí
AT yībùtìnízhìliáoguòchéngzhōnghuáshìjùqiúdànbáixuèzhèngxiàngmímàndàbxìbāolínbāliúkèlóngtóngyuánxìngzhuǎnhuàyīlìbàogàobìngwénxiànfùxí